IRCT20231123060147N1 IRCT 2024-01-12 Mazandaran University of Medical Sciences Investigation of therapeutic effect and monotherapy with lacosamide compared to carbamazepine in children with epilepsy Comparison of therapeutic effects and monotherapy with lacosamide versus carbamazepine in children with newly diagnosed epilepsy 2023-12-10 anticipated 100 Complete https://irct.ir/trial/73992 interventional Randomization: N/A, Blinding: Double blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Blinding description: The method of blinding in this study will be as follows, so that at the beginning of the study, an envelope that has only one code on it is randomly given to them, and the type of treatment group is determined in the envelope, and the envelope is opened by the pharmacy and the drug is already It will be prepared and delivered to the patient. 3 Epilepsy. Intervention 1: Intervention group: Lacosamide (Unimide brand) was started with a daily dose of 2 mg/kg/day divided into two doses (BD) and continued with an increase of 2 mg/kg/day every week to a maximum dose of 10 mg/kg/day if tolerated. Intervention 2: Intervention group: Carbamazepine (brand name Tegatard) with a dose of 5 mg/kg/day (BD) during the first week and with an increase of 5 mg/kg/day every week to a maximum dose of 20 mg/kg/day if tolerated. No - There is not a plan to make this available Justification or reason for not sharing IPD is There is no more information There is no more information